Mineralys Therapeutics, Inc. (MLYS)

29.04 +3.47 (+13.57%) USD  |  NASDAQ  |  Sep 02, 16:00
28.98 -0.06 (-0.21%) After-Hours: 07:51
More

Mineralys Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly)

Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for MLYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart
Start Trial

Historical Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Data

View and export this data back to . Start Trial.
Date Value

Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks
Start Trial
MapLight Therapeutics, Inc. --
Evommune, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade